Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01307813 · ClinicalTrials.gov registry record · NA

Apollo Overstitch, a Treat and Resect Model

A NA study, sponsored by University Hospitals Cleveland Medical Center.

Completed
Registry status
NA
Development phase
4
Enrollment target

NCT01307813 is a NA study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 4 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01307813, a NA study, has completed, sponsored by University Hospitals Cleveland Medical Center.

COMPLETED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

The Overstitch (Apollo Endosurgery, Austin, Texas) is an FDA cleared product which attaches to a standard double channel endoscope. The Overstitch can place sutures under endoscopic guidance, with the goal of reproducing standard surgical techniques. These would include hemostasis, tissue approximation, anastomosis formation, fixation of intraluminal devices, or repair/closure of mucosal or full thickness defects such as perforations or endoscopic mucosal resection (EMR) sites. Knot tying of the endoscopically placed sutures is provided by an endoscopic cinching device that passes through the channel of the endoscope. This feasibility trial will evaluate the ability of the Apollo suturing device (Overstitch) to endoscopically place sutures into normal mucosa, and then "tie" the sutures with the cinching device. These devices have been utilized effectively in explant, live porcine, and human cadaver colon and stomach models. In this treat and resect model, sutures would be placed in a segment of colon or stomach that is being surgically removed via open or laparoscopic technique for the treatment of benign or malignant disease. The sutures would be placed in a segment of normal mucosa remote to the pathology being surgically treated. In addition, the sutures will be placed under direct observation via laparoscopic or open visualization. After resection of the segment of colon, it will be evaluated grossly for level of suture placement, evidence of perforation, and quality of suture approximation with the cinching device.

Interventions

  • DEVICE Overstitch Endoscopic Suturing System

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2011-02
Est. Completion 2011-11
Phase NA

What the Registry Record Tells You About NCT01307813

The ClinicalTrials.gov registry entry for NCT01307813 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Overstitch Endoscopic Suturing System is the first listed.

NCT01307813 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01307813 about?

NCT01307813 is a clinical study titled "Apollo Overstitch, a Treat and Resect Model". The Overstitch (Apollo Endosurgery, Austin, Texas) is an FDA cleared product which attaches to a standard double channel endoscope. The Overstitch can place sutures under endoscopic guidance, with the goal of reproducing standard surgical techniques. These would include hemostasis, tissue approximat...

What is the current status of trial NCT01307813?

This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2011-02. Estimated completion is 2011-11.

What interventions are being tested in trial NCT01307813?

The interventions under investigation include: Overstitch Endoscopic Suturing System (DEVICE).

Who is sponsoring clinical trial NCT01307813?

This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.